MiniMed 720G Insulin Pump Class II Recall

FDA initiated a Class II recall affecting Medtronic MiniMed 720G Insulin Pumps and all related Paradigm, 600, and BLE 700 series infusion pumps. The recall addresses a defect where gravitational force changes when the pump is elevated or lowered relative to the infusion site can cause unintended over- or under-delivery of insulin. The affected products are distributed worldwide with US nationwide availability.

Healthcare providers and patients using these insulin pump models should be aware of the insulin delivery malfunction risk. Providers should identify patients with affected devices, monitor for dosing irregularities, and report any adverse events through FDA MedWatch. The recall is ongoing and manufacturers should implement corrective actions to address the gravitational force-related delivery issue.